ISORT Trademark

Trademark Overview

On Friday, March 22, 2019, a trademark application was filed for ISORT with the United States Patent and Trademark Office. The USPTO has given the ISORT trademark a serial number of 88352926. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 17, 2023. This trademark is owned by T-Cure Bioscience, Inc.. The ISORT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the fields of oncology, immunology, genetics, gene therapy, cell therapy, therapeutics and pharmaceutical development
isort

General Information

Serial Number88352926
Word MarkISORT
Filing DateFriday, March 22, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2020

Trademark Statements

Pseudo MarkI SORT
Goods and ServicesResearch and development services in the fields of oncology, immunology, genetics, gene therapy, cell therapy, therapeutics and pharmaceutical development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 10, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameT-Cure Bioscience, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVan Nuys, CA 91411
Party NameT-Cure Bioscience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVan Nuys, CA 91411

Trademark Events

Event DateEvent Description
Monday, April 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, September 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 28, 2022SOU EXTENSION 5 GRANTED
Thursday, September 15, 2022SOU EXTENSION 5 FILED
Wednesday, September 28, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 15, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 4, 2022SOU EXTENSION 4 GRANTED
Friday, March 4, 2022SOU EXTENSION 4 FILED
Friday, March 4, 2022SOU TEAS EXTENSION RECEIVED
Saturday, September 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 2, 2021SOU EXTENSION 3 GRANTED
Thursday, September 2, 2021SOU EXTENSION 3 FILED
Thursday, September 2, 2021SOU TEAS EXTENSION RECEIVED
Thursday, March 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 9, 2021SOU EXTENSION 2 GRANTED
Tuesday, March 9, 2021SOU EXTENSION 2 FILED
Tuesday, March 9, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, September 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 14, 2020SOU EXTENSION 1 GRANTED
Monday, September 14, 2020SOU EXTENSION 1 FILED
Monday, September 14, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, March 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 11, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 4, 2019ASSIGNED TO LIE
Friday, November 22, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 4, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 4, 2019NON-FINAL ACTION E-MAILED
Tuesday, June 4, 2019NON-FINAL ACTION WRITTEN
Monday, June 3, 2019ASSIGNED TO EXAMINER
Wednesday, April 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 26, 2019NEW APPLICATION ENTERED

Related Keywords

isort therapy development cell pharmaceutical gene therapeutics immunology services fields oncology